Propafenone Hcl
Product Images NDC 0591-0582

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propafenone Hcl (NDC 0591-0582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of the active ingredient Propafenone Hydrochloride (Propafenone HCl). The image shows the molecular arrangement including aromatic rings, hydroxyl group, amine group, and hydrochloride component.*

FDA Label Image

Image 2

Label for Propafenone Hydrochloride Tablets USP 150 mg by Actavis Pharma, Inc. The label indicates a package of 100 tablets, manufactured by Watson Pharma Private Limited in India and distributed by Actavis Pharma, Inc. It includes dosage information, storage conditions, and a barcode.*

FDA Label Image

Image 3

Label for Propafenone Hydrochloride Tablets USP, 225 mg, manufactured by Watson Pharma Private Limited and distributed by Actavis Pharma, Inc. The label specifies a 100 tablet count and prescription-only status, with storage instructions and a barcode. The product is identified by NDC 0591-0583-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.